A common cough medicine may slow cognitive decline in people with Parkinson’s disease dementia, a clinical trial has revealed ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

The £100m facility will focus on tackling diseases including cancer, dementia, eyesight loss, infectious diseases, and ...

Tens of thousands of people suffer needless heart attacks and strokes every year because they aren't taking ...

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

As new treatments emerge, timely diagnosis helps match patients with the most appropriate care when it can have the greatest ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

INmune Bio's ATM offering raises $19M ahead of Phase II results, but disappointing data and dilution signal risks. Read here ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...